(NASDAQ: WGS) Genedx Holdings's forecast annual revenue growth rate of 23.83% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 10.16%, and it is also forecast to beat the US market's average forecast revenue growth rate of 22.81%.
Genedx Holdings's revenue in 2026 is $402,190,000.On average, 10 Wall Street analysts forecast WGS's revenue for 2026 to be $15,568,879,312, with the lowest WGS revenue forecast at $14,446,514,082, and the highest WGS revenue forecast at $16,674,190,833. On average, 10 Wall Street analysts forecast WGS's revenue for 2027 to be $18,886,259,106, with the lowest WGS revenue forecast at $16,571,001,447, and the highest WGS revenue forecast at $21,102,374,021.
In 2028, WGS is forecast to generate $22,021,539,983 in revenue, with the lowest revenue forecast at $19,992,726,811 and the highest revenue forecast at $25,078,200,376.